Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diphtheria booster in adolescents with IBD
NCT03998215Completed
- Sponsor
- Medical University of Warsaw
- Start
- Dec 2012
- Primary completion
- Jan 2015
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Open-label trial of diphtheria + tetanus + acellular pertussis vaccine in diphtheria, sponsored by Medical University of Warsaw. Primary endpoint: Seroprotective antibody concentration at 8 weeks. Started Dec 2012; status: completed.
02
Drugs
diphtheria + tetanus + acellular pertussis vaccine
03
Conditions
diphtheria
Beyond the preview
Go deeper on NCT03998215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03998215.